Zhe Wang
Direktor/Vorstandsmitglied bei DELUXE FAMILY CO., LTD.
Aktive Positionen von Zhe Wang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DELUXE FAMILY CO., LTD. | Direktor/Vorstandsmitglied | 17.08.2018 | - |
Corporate Officer/Principal | 21.02.2020 | - | |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | 08.09.2020 | - |
Karriereverlauf von Zhe Wang
Statistik
International
China | 3 |
Operativ
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Sektoral
Finance | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
DELUXE FAMILY CO., LTD. | Finance |
Private Unternehmen | 1 |
---|---|
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Commercial Services |